October 07, 2023
2 min watch
Save
VIDEO: Paradigm shift needed in keratoconus and cross-linking
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — In this Healio Video Perspective from OSN New York, Parag A. Majmudar, MD, discusses the need for ophthalmologists to embrace a paradigm shift toward treating patients with keratoconus in the early stages of disease.
“Too many clinicians that I talk to are in the mindset that we don’t treat keratoconus until it gets past a certain stage,” Majmudar said. “We don’t do that for any other any other disease process — not heart disease, not glaucoma, not cataract. So, why are we doing that with keratoconus?”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Majmudar reports being a shareholder in and investigator in multiple clinical trials for Epion Therapeutics.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.